StockData

Journey Medical vs Rockwell Medical

DERM and RMTI side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How DERM and RMTI compare

Journey Medical is the larger company, worth 3.8 times as much as Rockwell Medical ($104M against $27.2M).

Journey Medical grew revenue faster over the last twelve months (20.9% versus −21.1% for Rockwell Medical).

Rockwell Medical keeps more of each dollar of sales as profit, with a net margin of −7.3% compared with −9.0% at Journey Medical.

Rockwell Medical scores higher on the StockData Score (11 against 7 for Journey Medical), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricDERMRMTI
Size and price
Market cap$104M$27.2M
Share price$3.70$6.76
Change, 1 year−51.9%−25.9%
Change, 5 years−56.4%−86.0%
Beta (5Y)2.01−0.02
Employees58157
StockData Score
Total score711 (better)
Valuation score23 (better)
Growth score11
Performance score33
Health score14 (better)
Dividend score00
Valuation
P/S1.5×0.4× (better)
P/B3.3×0.8× (better)
P/FCF–17.7×
FCF yield–5.7%
Fair value$5.98$33.27
Margin of safety38.1%79.7% (better)
Growth
Revenue growth (TTM)20.9% (better)−21.1%
Revenue growth, 5Y average6.8% (better)2.2%
Profitability
Gross margin65.5% (better)17.7%
Operating margin−4.4% (better)−6.5%
Net margin−9.0%−7.3% (better)
FCF margin–2.2%
Return on equity−23.8%−15.5% (better)
Return on invested capital−8.5% (better)−17.9%
Financial health
Debt / equity0.790.26 (better)
Interest coverage−0.8× (better)−4.0×
Current ratio1.593.25 (better)
Altman Z-score0.43 (better)−7.79
Piotroski F-score5 (better)2
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions37.8%0.05%
Held by insiders15.3%100%
Insider net buying, 12 months–−$11.6K
Short interest, % of float12.9%–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.